Hospital Acquired Pneumonia Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 78 pages | ID: HDC7ABE477CEEN
Market Monitor Global

Abstracts

Hospital-acquired pneumonia (HAP) or nosocomial pneumonia refers to any pneumonia contracted by a patient in a hospital at least 48–72 hours after being admitted. It is thus distinguished from community-acquired pneumonia. It is usually caused by a bacterial infection, rather than a virus.

This report contains market size and forecasts of Hospital Acquired Pneumonia Drugs in global, including the following market information:

Global Hospital Acquired Pneumonia Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Hospital Acquired Pneumonia Drugs Market Sales, 2017-2022, 2023-2028, (Kg)

Global top five Hospital Acquired Pneumonia Drugs companies in 2021 (%)

The global Hospital Acquired Pneumonia Drugs market was valued at 2888.7 million in 2021 and is projected to reach US$ 3191.8 million by 2028, at a CAGR of 1.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Phase II Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hospital Acquired Pneumonia Drugs include Basilea Pharmaceutica, Meiji Holdings, Cubist Pharmaceutical, Aridis Pharmaceutical, Valneva, Bayer, GlaxoSmithKline, Merck and Achaogen and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital Acquired Pneumonia Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hospital Acquired Pneumonia Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Hospital Acquired Pneumonia Drugs Market Segment Percentages, by Type, 2021 (%)

• Phase II
• Early Phase (Phase I & II)

Global Hospital Acquired Pneumonia Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Hospital Acquired Pneumonia Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Drug Store
• E-Commerce

Global Hospital Acquired Pneumonia Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Hospital Acquired Pneumonia Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hospital Acquired Pneumonia Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Hospital Acquired Pneumonia Drugs revenues share in global market, 2021 (%)

Key companies Hospital Acquired Pneumonia Drugs sales in global market, 2017-2022 (Estimated), (Kg)

Key companies Hospital Acquired Pneumonia Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Basilea Pharmaceutica
• Meiji Holdings
• Cubist Pharmaceutical
• Aridis Pharmaceutical
• Valneva
• Bayer
• GlaxoSmithKline
• Merck
• Achaogen
• AstraZeneca

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hospital Acquired Pneumonia Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hospital Acquired Pneumonia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HOSPITAL ACQUIRED PNEUMONIA DRUGS OVERALL MARKET SIZE

2.1 Global Hospital Acquired Pneumonia Drugs Market Size: 2021 VS 2028
2.2 Global Hospital Acquired Pneumonia Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Hospital Acquired Pneumonia Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Hospital Acquired Pneumonia Drugs Players in Global Market
3.2 Top Global Hospital Acquired Pneumonia Drugs Companies Ranked by Revenue
3.3 Global Hospital Acquired Pneumonia Drugs Revenue by Companies
3.4 Global Hospital Acquired Pneumonia Drugs Sales by Companies
3.5 Global Hospital Acquired Pneumonia Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Hospital Acquired Pneumonia Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Hospital Acquired Pneumonia Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hospital Acquired Pneumonia Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Hospital Acquired Pneumonia Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Hospital Acquired Pneumonia Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Hospital Acquired Pneumonia Drugs Market Size Markets, 2021 & 2028
  4.1.2 Phase II
  4.1.3 Early Phase (Phase I & II)
4.2 By Type - Global Hospital Acquired Pneumonia Drugs Revenue & Forecasts
  4.2.1 By Type - Global Hospital Acquired Pneumonia Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Hospital Acquired Pneumonia Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Hospital Acquired Pneumonia Drugs Sales & Forecasts
  4.3.1 By Type - Global Hospital Acquired Pneumonia Drugs Sales, 2017-2022
  4.3.2 By Type - Global Hospital Acquired Pneumonia Drugs Sales, 2023-2028
  4.3.3 By Type - Global Hospital Acquired Pneumonia Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Hospital Acquired Pneumonia Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hospital Acquired Pneumonia Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Drug Store
  5.1.5 E-Commerce
5.2 By Application - Global Hospital Acquired Pneumonia Drugs Revenue & Forecasts
  5.2.1 By Application - Global Hospital Acquired Pneumonia Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Hospital Acquired Pneumonia Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Hospital Acquired Pneumonia Drugs Sales & Forecasts
  5.3.1 By Application - Global Hospital Acquired Pneumonia Drugs Sales, 2017-2022
  5.3.2 By Application - Global Hospital Acquired Pneumonia Drugs Sales, 2023-2028
  5.3.3 By Application - Global Hospital Acquired Pneumonia Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Hospital Acquired Pneumonia Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hospital Acquired Pneumonia Drugs Market Size, 2021 & 2028
6.2 By Region - Global Hospital Acquired Pneumonia Drugs Revenue & Forecasts
  6.2.1 By Region - Global Hospital Acquired Pneumonia Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Hospital Acquired Pneumonia Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Hospital Acquired Pneumonia Drugs Sales & Forecasts
  6.3.1 By Region - Global Hospital Acquired Pneumonia Drugs Sales, 2017-2022
  6.3.2 By Region - Global Hospital Acquired Pneumonia Drugs Sales, 2023-2028
  6.3.3 By Region - Global Hospital Acquired Pneumonia Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Hospital Acquired Pneumonia Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Hospital Acquired Pneumonia Drugs Sales, 2017-2028
  6.4.3 US Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.4.4 Canada Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.4.5 Mexico Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Hospital Acquired Pneumonia Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Hospital Acquired Pneumonia Drugs Sales, 2017-2028
  6.5.3 Germany Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.5.4 France Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.5.5 U.K. Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.5.6 Italy Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.5.7 Russia Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.5.9 Benelux Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Hospital Acquired Pneumonia Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Hospital Acquired Pneumonia Drugs Sales, 2017-2028
  6.6.3 China Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.6.4 Japan Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.6.5 South Korea Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.6.7 India Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Hospital Acquired Pneumonia Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Hospital Acquired Pneumonia Drugs Sales, 2017-2028
  6.7.3 Brazil Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.7.4 Argentina Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Sales, 2017-2028
  6.8.3 Turkey Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.8.4 Israel Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Hospital Acquired Pneumonia Drugs Market Size, 2017-2028
  6.8.6 UAE Hospital Acquired Pneumonia Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Basilea Pharmaceutica
  7.1.1 Basilea Pharmaceutica Corporate Summary
  7.1.2 Basilea Pharmaceutica Business Overview
  7.1.3 Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Major Product Offerings
  7.1.4 Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Basilea Pharmaceutica Key News
7.2 Meiji Holdings
  7.2.1 Meiji Holdings Corporate Summary
  7.2.2 Meiji Holdings Business Overview
  7.2.3 Meiji Holdings Hospital Acquired Pneumonia Drugs Major Product Offerings
  7.2.4 Meiji Holdings Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Meiji Holdings Key News
7.3 Cubist Pharmaceutical
  7.3.1 Cubist Pharmaceutical Corporate Summary
  7.3.2 Cubist Pharmaceutical Business Overview
  7.3.3 Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Major Product Offerings
  7.3.4 Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Cubist Pharmaceutical Key News
7.4 Aridis Pharmaceutical
  7.4.1 Aridis Pharmaceutical Corporate Summary
  7.4.2 Aridis Pharmaceutical Business Overview
  7.4.3 Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Major Product Offerings
  7.4.4 Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Aridis Pharmaceutical Key News
7.5 Valneva
  7.5.1 Valneva Corporate Summary
  7.5.2 Valneva Business Overview
  7.5.3 Valneva Hospital Acquired Pneumonia Drugs Major Product Offerings
  7.5.4 Valneva Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Valneva Key News
7.6 Bayer
  7.6.1 Bayer Corporate Summary
  7.6.2 Bayer Business Overview
  7.6.3 Bayer Hospital Acquired Pneumonia Drugs Major Product Offerings
  7.6.4 Bayer Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 Bayer Key News
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Corporate Summary
  7.7.2 GlaxoSmithKline Business Overview
  7.7.3 GlaxoSmithKline Hospital Acquired Pneumonia Drugs Major Product Offerings
  7.7.4 GlaxoSmithKline Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 GlaxoSmithKline Key News
7.8 Merck
  7.8.1 Merck Corporate Summary
  7.8.2 Merck Business Overview
  7.8.3 Merck Hospital Acquired Pneumonia Drugs Major Product Offerings
  7.8.4 Merck Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2017-2022)
  7.8.5 Merck Key News
7.9 Achaogen
  7.9.1 Achaogen Corporate Summary
  7.9.2 Achaogen Business Overview
  7.9.3 Achaogen Hospital Acquired Pneumonia Drugs Major Product Offerings
  7.9.4 Achaogen Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2017-2022)
  7.9.5 Achaogen Key News
7.10 AstraZeneca
  7.10.1 AstraZeneca Corporate Summary
  7.10.2 AstraZeneca Business Overview
  7.10.3 AstraZeneca Hospital Acquired Pneumonia Drugs Major Product Offerings
  7.10.4 AstraZeneca Hospital Acquired Pneumonia Drugs Sales and Revenue in Global (2017-2022)
  7.10.5 AstraZeneca Key News

8 GLOBAL HOSPITAL ACQUIRED PNEUMONIA DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Hospital Acquired Pneumonia Drugs Production Capacity, 2017-2028
8.2 Hospital Acquired Pneumonia Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Hospital Acquired Pneumonia Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 HOSPITAL ACQUIRED PNEUMONIA DRUGS SUPPLY CHAIN ANALYSIS

10.1 Hospital Acquired Pneumonia Drugs Industry Value Chain
10.2 Hospital Acquired Pneumonia Drugs Upstream Market
10.3 Hospital Acquired Pneumonia Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Hospital Acquired Pneumonia Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Hospital Acquired Pneumonia Drugs in Global Market
Table 2. Top Hospital Acquired Pneumonia Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Hospital Acquired Pneumonia Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Hospital Acquired Pneumonia Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Hospital Acquired Pneumonia Drugs Sales by Companies, (Kg), 2017-2022
Table 6. Global Hospital Acquired Pneumonia Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Hospital Acquired Pneumonia Drugs Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Hospital Acquired Pneumonia Drugs Product Type
Table 9. List of Global Tier 1 Hospital Acquired Pneumonia Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital Acquired Pneumonia Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Hospital Acquired Pneumonia Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Hospital Acquired Pneumonia Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Hospital Acquired Pneumonia Drugs Sales (Kg), 2017-2022
Table 15. By Type - Global Hospital Acquired Pneumonia Drugs Sales (Kg), 2023-2028
Table 16. By Application – Global Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Hospital Acquired Pneumonia Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Hospital Acquired Pneumonia Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Hospital Acquired Pneumonia Drugs Sales (Kg), 2017-2022
Table 20. By Application - Global Hospital Acquired Pneumonia Drugs Sales (Kg), 2023-2028
Table 21. By Region – Global Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Hospital Acquired Pneumonia Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Hospital Acquired Pneumonia Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Hospital Acquired Pneumonia Drugs Sales (Kg), 2017-2022
Table 25. By Region - Global Hospital Acquired Pneumonia Drugs Sales (Kg), 2023-2028
Table 26. By Country - North America Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Hospital Acquired Pneumonia Drugs Sales, (Kg), 2017-2022
Table 29. By Country - North America Hospital Acquired Pneumonia Drugs Sales, (Kg), 2023-2028
Table 30. By Country - Europe Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Hospital Acquired Pneumonia Drugs Sales, (Kg), 2017-2022
Table 33. By Country - Europe Hospital Acquired Pneumonia Drugs Sales, (Kg), 2023-2028
Table 34. By Region - Asia Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Hospital Acquired Pneumonia Drugs Sales, (Kg), 2017-2022
Table 37. By Region - Asia Hospital Acquired Pneumonia Drugs Sales, (Kg), 2023-2028
Table 38. By Country - South America Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Hospital Acquired Pneumonia Drugs Sales, (Kg), 2017-2022
Table 41. By Country - South America Hospital Acquired Pneumonia Drugs Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Sales, (Kg), 2023-2028
Table 46. Basilea Pharmaceutica Corporate Summary
Table 47. Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Product Offerings
Table 48. Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Meiji Holdings Corporate Summary
Table 50. Meiji Holdings Hospital Acquired Pneumonia Drugs Product Offerings
Table 51. Meiji Holdings Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Cubist Pharmaceutical Corporate Summary
Table 53. Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Product Offerings
Table 54. Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Aridis Pharmaceutical Corporate Summary
Table 56. Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Product Offerings
Table 57. Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. Valneva Corporate Summary
Table 59. Valneva Hospital Acquired Pneumonia Drugs Product Offerings
Table 60. Valneva Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Bayer Corporate Summary
Table 62. Bayer Hospital Acquired Pneumonia Drugs Product Offerings
Table 63. Bayer Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. GlaxoSmithKline Corporate Summary
Table 65. GlaxoSmithKline Hospital Acquired Pneumonia Drugs Product Offerings
Table 66. GlaxoSmithKline Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. Merck Corporate Summary
Table 68. Merck Hospital Acquired Pneumonia Drugs Product Offerings
Table 69. Merck Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 70. Achaogen Corporate Summary
Table 71. Achaogen Hospital Acquired Pneumonia Drugs Product Offerings
Table 72. Achaogen Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 73. AstraZeneca Corporate Summary
Table 74. AstraZeneca Hospital Acquired Pneumonia Drugs Product Offerings
Table 75. AstraZeneca Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 76. Hospital Acquired Pneumonia Drugs Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 77. Global Hospital Acquired Pneumonia Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Hospital Acquired Pneumonia Drugs Production by Region, 2017-2022 (Kg)
Table 79. Global Hospital Acquired Pneumonia Drugs Production by Region, 2023-2028 (Kg)
Table 80. Hospital Acquired Pneumonia Drugs Market Opportunities & Trends in Global Market
Table 81. Hospital Acquired Pneumonia Drugs Market Drivers in Global Market
Table 82. Hospital Acquired Pneumonia Drugs Market Restraints in Global Market
Table 83. Hospital Acquired Pneumonia Drugs Raw Materials
Table 84. Hospital Acquired Pneumonia Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Hospital Acquired Pneumonia Drugs Downstream
Table 86. Hospital Acquired Pneumonia Drugs Downstream Clients in Global Market
Table 87. Hospital Acquired Pneumonia Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Hospital Acquired Pneumonia Drugs Segment by Type
Figure 2. Hospital Acquired Pneumonia Drugs Segment by Application
Figure 3. Global Hospital Acquired Pneumonia Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hospital Acquired Pneumonia Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hospital Acquired Pneumonia Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Hospital Acquired Pneumonia Drugs Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Hospital Acquired Pneumonia Drugs Revenue in 2021
Figure 9. By Type - Global Hospital Acquired Pneumonia Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Hospital Acquired Pneumonia Drugs Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Hospital Acquired Pneumonia Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Hospital Acquired Pneumonia Drugs Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Hospital Acquired Pneumonia Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Hospital Acquired Pneumonia Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Hospital Acquired Pneumonia Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Hospital Acquired Pneumonia Drugs Sales Market Share, 2017-2028
Figure 19. US Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Hospital Acquired Pneumonia Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Hospital Acquired Pneumonia Drugs Sales Market Share, 2017-2028
Figure 24. Germany Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Hospital Acquired Pneumonia Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Hospital Acquired Pneumonia Drugs Sales Market Share, 2017-2028
Figure 33. China Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Hospital Acquired Pneumonia Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Hospital Acquired Pneumonia Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Hospital Acquired Pneumonia Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Hospital Acquired Pneumonia Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Hospital Acquired Pneumonia Drugs Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Hospital Acquired Pneumonia Drugs by Region, 2021 VS 2028
Figure 50. Hospital Acquired Pneumonia Drugs Industry Value Chain
Figure 51. Marketing Channels